Scribe Therapeutics Financials - Benzinga

Scribe Therapeutics Inc

SCTXNASDAQ

Trade with Public

Trade with Public

$29.42

-0.32-1.08%

At close: Sep 11, 5:00 PM EST

$30.15

0.411.38%

Pre-Market: 4:00 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

Scribe Therapeutics Financials

Scribe Therapeutics (SCTX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Scribe Therapeutics Q3 EPS $(2.62) Misses $(1.05) Estimate, Sales $1.918M Miss $3.113M Estimate

Scribe Therapeutics (NASDAQ:SCTX) reported quarterly losses of $(2.62) per share which missed the analyst consensus estimate of $(1.05) by 149.52 percent. The company reported quarterly sales of $1.918 million which

Benzinga Newsdesk